Drug class
Licorice-derived triterpenoid; anti-ulcer agent and 11β-hydroxysteroid dehydrogenase inhibitor
Mechanism of action
A glycyrrhetinic-acid derivative that inhibits 11β-hydroxysteroid dehydrogenase, reducing conversion of cortisol to cortisone in mineralocorticoid-sensitive tissues. Its gastroprotective actions have been attributed to increased mucosal resistance and effects on mucus secretion; the mechanism is not fully defined.
General use cases
- Historically used for gastric and other digestive-tract ulcers in some countries; availability and authorised status are limited, and use can cause sodium retention, hypertension and hypokalaemia
For general informational purposes only. Do not rely on, cross-reference, cite or use this information as evidence or support for legal, regulatory, commercial or other claims.
